Orphelia Pharma

City:

Paris

Country:

France

Published Applications:

Last publication date:

2020-06-18

Patent Grants:

Last grant date:

2023-08-22

Top Inventors for applications by Orphelia Pharma

These are the the leading inventors for applications assigned to Orphelia Pharma:

Charles Uzarama 1 Laval, Canada
Patrick Gosselin 1 Laval, Canada
Mathieu SCHMITT 1 Paris, France
Lionel TORTOLANO 1 Paris, France

Jérémy BASTID 1 Tassin La Demi Lune, France
Marie-Pierre FLAMENT 1 Phalempin, France
Maxime ANNEREAU 1 Vincennes, France
Samuel Abbou 1 Paris, France

François LEMARE 1 Suresnes, France
Hugues BIENAYME 1 Saint-Symphorien-d'Ozon, France

Recent patent applications by Orphelia Pharma

Orphelia Pharma based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-06-18 ✅ Patent 11,730,732 granted on 2023-08-22

US20200188390A1

Human necessities

Oral suspension of temozolomide

#2 | 2019-03-07 ✅ Patent 10,813,898 granted on 2020-10-27

US20190070138A1

Human necessities

Solid dosage forms of vigabatrin

Also check out Orphelia Pharma's (Paris, France) applicant profile with 2 patent applications submitted.

AssigneeID:

159573 ⎘